Suryadevara Varun, Merugu Chandhana, Perumal Nandhini L, Sahoo Jayaprakash, Kamalanathan Sadishkumar, Naik Dukhabandhu
Department of Endocrinology, Jawaharlal Institute of Post Graduate Medical Education and Research (JIPMER), Puducherry, India.
J Family Med Prim Care. 2022 May;11(5):2228-2230. doi: 10.4103/jfmpc.jfmpc_1405_21. Epub 2022 May 14.
COVID-19 (corona virus disease 2019), caused by the severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has spread throughout the globe and affected millions of people worldwide. Here, we report a patient with autoimmune polyglandular syndrome type 2 who presented with adrenal crisis, precipitated by COVID-19. We intend to highlight the importance of stress dosing in preventing adrenal crisis in patients with adrenal insufficiency (AI). A uniform structured education programme is needed to improve knowledge and practices in patients with AI in our country.
2019冠状病毒病（COVID-19）由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起，已在全球范围内传播，影响了全球数百万人。在此，我们报告1例2型自身免疫性多腺体综合征患者，该患者因COVID-19引发肾上腺危象。我们旨在强调应激剂量在预防肾上腺功能不全（AI）患者发生肾上腺危象中的重要性。我国需要一个统一的结构化教育项目，以提高AI患者的知识水平和实践能力。
